Samsara BioCapital, LLC

Q1 2023 13F Holdings Report, Restatement, Options Holdings

Signature - Title
Miran Ahmad - Chief Financial Officer
Location
Palo Alto, CA
Options holdings as of
March 31, 2023
Notional value $
$0
Number of holdings
0
Date filed
8/14/2023, 04:57 PM
Description
All US holdings of this investor are reported in this report.
Previous filing
Q4 2022 - Feb 14, 2023
Next filing
Q2 2023 - Aug 14, 2023
Stock holdings
Showing options holdings, see here for stock holdings
Sym Company Class Option Share Change Activity * Price $ Shares Notional Value
Filing 2023 Q1 - Restatement compared to 2022 Q4 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Miran Ahmad Chief Financial Officer Palo Alto, California 8/14/2023

This amendment filing is a restatement of the values in the information table and the information table entry total included in the Report Summary and supersedes the prior filing.